1-20 of 31
Felix Keil
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Real-World Comparison of Outcomes of Patients Treated with HMA Monotherapy Versus HMA-Ven - Insights from 1634 Patients Included within the Austrian Myeloid Registry of the AGMT Study Group

Lisa Pleyer, Patrick Klammer, Manuel Drost, Hubert Angermann, Felix Keil, Verena Petzer, Sonja Heibl, Jennifer Moritz, Michael Girschikofsky, Margarete Stampfl-Mattersberger, Angelika Pichler, Bernd L. Hartmann, Gregor Aschauer, Clemens Schmitt, Sonia Vallet, Szilvia Boros, Petra Pichler, Andrea Hammerl-Steiner, Felix Renneberg, Susanne Schnabel, Dilyan Majjiga, Thomas Melchardt, Alexander Egle, Michael Leisch, Richard Greil
Journal: Blood
Blood (2024) 144 (Supplement 1): 3793.
https://doi.org/10.1182/blood-2024-207230
Published: 2024
Journal Articles

PET-Guided Brecadd in Older Patients with Advanced-Stage Classic Hodgkin Lymphoma: Results of the Phase 2 Part of the GHSG HD21 Trial

Justin Ferdinandus, Helen Kaul, Alexander Fosså, Andreas Hüttmann, Felix Keil, Yon-Dschun Ko, Felicitas Hitz, Michaela Schwarz, Corinna Trenker, Andrea Kerkhoff, Peter Staib, Kai Wille, Irmgard Dresel, Dennis Hahn, Bernd Hertenstein, Peter Moosmann, Ulrich Mey, Stefan Balabanov, Tasman Armytage, Fernando Roncolato, Johannes Christian Hellmuth, Stefanie Kreissl, Michael Fuchs, Gundolf Schneider, Hishan Tharmaseelan, Dennis A Eichenauer, Bastian von Tresckow, Peter Borchmann, Paul J. Bröckelmann
Journal: Blood
Blood (2024) 144 (Supplement 1): 568.
https://doi.org/10.1182/blood-2024-207946
Published: 2024
Journal Articles

Validation of Recent Response Criteria (ELN-22, IWG-23 and PB-CR) in 1634 MDS/CMML/AML Patients Treated with HMA or HMA-Ven Using CPH Models and a CPH Deep Neural Network - Can or Should Response Criteria be Harmonized for Similarly Treated Patients?

Lisa Pleyer, Marc Vaisband, Patrick Klammer, Manuel Drost, Hubert Angermann, Felix Keil, Verena Petzer, Sonja Heibl, Jennifer Moritz, Michael Girschikofsky, Margarete Stampfl-Mattersberger, Angelika Pichler, Bernd L. Hartmann, Gregor Aschauer, Clemens Schmitt, Sonia Vallet, Szilvia Boros, Petra Pichler, Andrea Hammerl-Steiner, Felix Renneberg, Dilyan Majjiga, Gudrun Russ, Alexander Egle, Michael Leisch, Thomas Melchardt, Nadja Zaborsky, Viktoria Faber, Jan Philipp Bewersdorf, Amer M. Zeidan, Jan Hasenauer, Richard Greil
Journal: Blood
Blood (2024) 144 (Supplement 1): 7511.
https://doi.org/10.1182/blood-2024-208073
Published: 2024
Journal Articles

Comprehensive Analysis of Treatment Related Morbidity and Progression -Free Survival in the GHSG Phase III HD21 Trial

Peter Borchmann, Alden Moccia, Richard Greil, Gundolf Schneider, Mark S. Hertzberg, Valdete Schaub, Andreas Huettmann, Felix Keil, Valdete Schaub, Mathias Hänel, Urban Novak, Julia Meissner, Andreas Zimmermann, Stephan Mathas, Josée M Zijlstra, Alexander Fosså, Andreas Viardot, Bernd Hertenstein, Sonja Martin, Pratyush Giri, Peter Kamper, Daniel L. Molin, Stefanie Kreissl, Justin Ferdinandus, Michael Fuchs, Andreas Rosenwald, Wolfram Klapper, Hans Eich, Christian Baues, Michael Hallek, Markus Dietlein, Carsten Kobe, Volker Diehl
Journal: Blood
Blood (2023) 142 (Supplement 1): 3057.
https://doi.org/10.1182/blood-2023-188720
Published: 2023
Journal Articles

Cox Proportional Hazards Deep Neural Network Identifies Peripheral Blood Complete Remission (PB-CR) to be at Least Equivalent to Morphologic CR in Predicting Outcomes of Patients Treated with Azacitidine - a Prospective Cohort Study By the AGMT

Lisa Pleyer, Marc Vaisband, Michael Pfeilstocker, Reinhard Stauder, Sonja Heibl, Heinz Sill, Michael Girschikofsky, Margarete Stampfl-Mattersberger, Christoph Tinchon, Bernd L. Hartmann, Andreas Petzer, Martin Schreder, Clemens A. Schmitt, Sonia Vallet, Thomas Melchardt, Lukas Scagnetti, Armin Zebisch, Sigrid Machherndl-Spandl, Dominik Wolf, Felix Keil, Jan Hasenauer, Richard Greil
Journal: Blood
Blood (2022) 140 (Supplement 1): 1346–1349.
https://doi.org/10.1182/blood-2022-168521
Published: 2022
Journal Articles

A Randomized Phase II Trial Comparing BeEAM with BEAM As Conditioning Regimen for Autologous Stem Cell Transplantation in Lymphoma Patients

Felix Keil, Antonia Maria Susanne Müller, Andrea Berghold, Veronika Buxhofer-Ausch, Judith Schuster, Regina Riedl, Corinne Vorburger, Alexandra Boehm, Michael Panny, Thomas Noesslinger, Richard Greil, Panagiotis Samaras, Thomas Pabst
Journal: Blood
Blood (2022) 140 (Supplement 1): 1180–1182.
https://doi.org/10.1182/blood-2022-157917
Published: 2022
Journal Articles

Treatment Related Morbidity in Patients with Classical Hodgkin Lymphoma: Results of the Ongoing, Randomized Phase III HD21 Trial By the German Hodgkin Study Group

Peter Borchmann, Alden Moccia, Richard Greil, Mark Hertzberg, Valdete Schaub, Andreas Hüttmann, Felix Keil, Judith Dierlamm, Mathias Haenel, Urban Novak, Julia Meissner, Andreas Zimmermann, Stephan Mathas, Josée M. Zijlstra, Alexander Fosså, Andreas Viardot, Bernd Hertenstein, Sonja Martin, Pratyush Giri, Peter Kamper, Daniel Molin, Stefanie Kreissl, Michael Fuchs, Gundolf Schneider, Andreas Rosenwald, Wolfram Klapper, Hans Eich, Christian Baues, Michael Hallek, Markus Dietlein, Carsten Kobe, Volker Diehl, Andreas Engert
Journal: Blood
Blood (2022) 140 (Supplement 1): 771–773.
https://doi.org/10.1182/blood-2022-165917
Published: 2022
Journal Articles

Real World Results of Multiple Myeloma Patients - Low Mortality Rate from First-Line to Second-Line Treatment

Felix Keil, Petra Attalla, Adelheid Seebacher, Sabine Burger, Elisabeth Koller, Thamer Sliwa, Claudia Laschan, Andreas Krauter, Michael Pfeilstöcker, Michael Fillitz
Journal: Blood
Blood (2022) 140 (Supplement 1): 12598–12599.
https://doi.org/10.1182/blood-2022-157969
Published: 2022
Journal Articles

Peripheral Blood Complete Remission Provides Added Value to the Classical Definition of Morphologic Complete Remission - a Prospective Cohort Study of 1441 Patients with MDS, CMML and AML Treated within the Austrian Azacitidine Registry

Lisa Pleyer, Michael Pfeilstocker, Reinhard Stauder, Sonja Heibl, Heinz Sill, Michael Girschikofsky, Margarete Stampfl-Mattesberger, Christoph Tinchon, Bernd Hartmann, Andreas Petzer, Branka Petricevic, Clemens A. Schmitt, Sonja Vallet, Klaus Geissler, Wolfgang R. Sperr, Michael Leisch, Alexander Egle, Thomas Melchardt, Gudrun Piringer, Armin Zebisch, Sigrid Machherndl-Spandl, Dominik Wolf, Felix Keil, Hubert Angermann, Manuel Drost, Julian Larcher-Senn, Richard Greil
Journal: Blood
Blood (2021) 138 (Supplement 1): 3387.
https://doi.org/10.1182/blood-2021-145401
Published: 2021
Journal Articles

Hereditary α tryptasemia is a valid genetic biomarker for severe mediator-related symptoms in mastocytosis

Clinical Trials & Observations
Georg Greiner, Bettina Sprinzl, Aleksandra Górska, Franz Ratzinger, Michael Gurbisz, Nadine Witzeneder, Klaus G. Schmetterer, Bettina Gisslinger, Goekhan Uyanik, Emir Hadzijusufovic, Harald Esterbauer, Karoline V. Gleixner, Maria T. Krauth, Michael Pfeilstöcker, Felix Keil, Heinz Gisslinger, Boguslaw Nedoszytko, Marek Niedoszytko, Wolfgang R. Sperr, Peter Valent, Gregor Hoermann
Journal: Blood
Blood (2021) 137 (2): 238–247.
https://doi.org/10.1182/blood.2020006157
Published: 2021
Includes: Supplemental data
Journal Articles

Overexpression of PD-L1 Correlates with JAK2 -V617F Mutational Burden and Is Associated with Chromosome 9p Uniparental Disomy in MPN

Jelena D. Milosevic Feenstra, PhD, Fiorella Schischlik, PhD, Roland Jäger, PhD, Daniel Ivanov, MSc, Gregor Eisenwort, MD PhD, Alexandra Keller, PhD, Michael Schuster, PhD, Emir Hadzijusufovic, DVM, Maria-Theresa Krauth, MD, Robert Spörk, MSc, Bettina Gisslinger, MSc, Elisabeth Koller, MD, Michael Fillitz, MD, Michael Pfeilstocker, MD, Thamer Sliwa, MD, Felix Keil, MD, Christoph Bock, PhD, Heinz Gisslinger, MD, Robert Kralovics, PhD, Peter Valent, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 24.
https://doi.org/10.1182/blood-2020-137447
Published: 2020
Journal Articles

Phenotyping of Disease-Initiating CD34 + /CD38 ─ Stem Cells in BCR-ABL1 ─ MPN Reveals Expression of Multiple Cytokine Receptors and Resistance-Related Antigens

Daniel Ivanov, MSc, Jelena D. Milosevic Feenstra, PhD, Gregor Eisenwort, MD PhD, Robert Spörk, MSc, Alexandra Keller, PhD, Barbara Peter, Michael Willmann, Georg Greiner, Gabriele Stefanzl, Katharina Slavnitsch, Gregor Hoermann, Sybille Hofer, Wolfgang R. Sperr, MD, Heinz Sill, MD, Peter Bettelheim, MD, Klaus Geissler, MD, Elisabeth Koller, Michael Fillitz, MD, Michael Pfeilstocker, MD, Thomas Rülicke, Thamer Sliwa, MD, Felix Keil, MD, Robert Kralovics, PhD, Peter Valent, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 53.
https://doi.org/10.1182/blood-2020-140477
Published: 2020
Journal Articles

Long-Time Follow-up of 888 Patients Diagnosed with CLL on a Single Center: Comorbidities, Time-to-Treatment and Comparison between Treated and Untreated Patients

Felix Keil, MD, Lisa Obenaus, BSc, Victor Rathkolb, MD, Michael Leiner, MD, Robert Spörk, MSc, Elisabeth Koller, MD, Ernst Forjan, MD, Ralph Simanek, MD, Michael Panny, MD, Daniel Lechner, MD, Alexandra Böhm, MD, Anabel Schönmetzler, MD, Theresia Kornberger, MD, Thomas Noesslinger, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5458.
https://doi.org/10.1182/blood-2019-122024
Published: 2019
Journal Articles

Expanding on Current Definitions of Hematologic Improvement in MDS, CMML and AML: Landmark Analyses of 1301 Patients Treated with Azacitidine in the Austrian Registry of Hypomethylating Agents By the AGMT-Study Group

Lisa Pleyer, Michael Pfeilstocker, MD, Reinhard Stauder, MD MSc, Sonja Heibl, MD, Heinz Sill, MD, Michael Girschikofsky, MD, Margarete Stampfl-Mattersberger, MD, Christoph Tinchon, MD, Andreas Petzer, MD, Clemens A. Schmitt, MD, Sonia Vallet, MD, Inga Mandac, MD, Klaus Geissler, MD, Wolfgang R. Sperr, MD, Michael Leisch, MD, Alexander Egle, MD, Thomas Melchardt, MD PhD, Julia Fusinato, BSc, Gudrun Piringer, MD MSc, Armin Zebisch, MD, Sigrid Machherndl-Spandl, MD, Dominik Wolf, MD, Felix Keil, MD, Richard Greil, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3821.
https://doi.org/10.1182/blood-2019-128153
Published: 2019
Journal Articles

Multiple Myeloma and Renal Impairment: Analysis of Induction Therapy Strategies and Outcome after Autologous Stem Cell Transplantation

Thomas Reiter, MD, Marlies Antlanger, Alexandra Böhm, Wolfgang Lamm, Max Gornicec, Ella Willenbacher, MD, David Nachbauer, Werner Rabitsch, Daniel Lechner, MD, Hildegard Greinix, Felix Keil, MD, Heinz Gisslinger, Hermine Agis, MD, Maria-Theresa Krauth, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5424.
https://doi.org/10.1182/blood.V130.Suppl_1.5424.5424
Published: 2017
Journal Articles

Clinical, Hematological, and Biologic Characteristics in Chronic Myelomonocytic Leukemia Patients with a JAK2 V617F Mutation

Klaus Geissler, MD, Agnes Barna, MSc, Eva Jäger, BSc, Temeida Alendar, Elmir Ljubuncic, Ruth Jilch, MD, Thomas Nösslinger, MD, Michael Pfeilstöcker, MD, Heinz Tüchler, MD, Regina Reisner, MD, Thamer Sliwa, MD, Felix Keil, MD, Sonja Burgstaller, MD, Josef Thaler, MD, Sigrid Machherndl-Spandl, MD, Otto Zach, PhD, Ansgar Weltermann, MD, Peter Bettelheim, MD, Reinhard Stauder, MD, Ilse Schwarzinger, MD, Gregor Hörmann, MD, Ulrich Jäger, MD, Wolfgang R. Sperr, MD, Paul Knöbl, MD PhD, Bruno Schneeweiss, MD, Jörg Berger, MD, Rajko Kusec, MD PhD, Leopold Öhler, MD, Armin Zebisch, MD, Heinz Sill, Ulrich Germing, Peter Valent, MD
Journal: Blood
Blood (2016) 128 (22): 3189.
https://doi.org/10.1182/blood.V128.22.3189.3189
Published: 2016
Journal Articles

Treatment of High Risk Aggressive B Cell Lymphomas with DA EPOCH R- a Retrospective Analysis

Michael Panny, MD, Katharina Troppan, MD, Peter Neumeister, MD, Thomas Nösslinger, MD, Felix Keil, MD
Journal: Blood
Blood (2016) 128 (22): 5413.
https://doi.org/10.1182/blood.V128.22.5413.5413
Published: 2016
Journal Articles

High Spontaneous In Vitro Myeloid Colony Formation in Chronic Myelomonocytic Leukemia is Associated with Mutations in Rasopathy Genes, Myeloproliferation and Inferior Prognosis

Klaus Geissler, MD, Agnes Barna, MSc, Eva Jäger, BSc, Temeida Alendar, Elmir Ljubuncic, Ruth Jilch, MD, Thomas Nösslinger, MD, Michael Pfeilstöcker, MD, Heinz Tüchler, MD, Regina Reisner, MD, Thamer Sliwa, MD, Felix Keil, MD, Sonja Burgstaller, MD, Josef Thaler, MD, Sigrid Machherndl-Spandl, MD, Otto Zach, PhD, Ansgar Weltermann, MD, Peter Bettelheim, MD, Reinhard Stauder, MD, Ilse Schwarzinger, MD, Gregor Hörmann, MD, Ulrich Jäger, MD, Wolfgang R. Sperr, MD, Paul Knöbl, MD PhD, Bruno Schneeweiss, MD, Jörg Berger, MD, Rajko Kusec, MD PhD, Leopold Öhler, MD, Armin Zebisch, MD, Heinz Sill, Ulrich Germing, Peter Valent, MD
Journal: Blood
Blood (2016) 128 (22): 5503.
https://doi.org/10.1182/blood.V128.22.5503.5503
Published: 2016
Journal Articles

Autologous Stem Cell Transplantation with Benda-Eam (Bendamustine, Etoposide, Cytarabine, Melphalan) in Aggressive Non Hodgkin and Hodgkin´s Lymphoma

Thomas Noesslinger, MD, Michael Panny, MD, Michaela Moestl, MD, Elisabeth Koller, MD, Felix Keil, MD
Journal: Blood
Blood (2016) 128 (22): 2265.
https://doi.org/10.1182/blood.V128.22.2265.2265
Published: 2016
Journal Articles

Autologous Stem Cell Transplantation with Benda-BEAM (Bendamustine, Etoposide, Cytarabine, Melphalan) in Aggressive Non Hodgkin and Hodgkin´s Lymphoma

Thomas Noesslinger, MD, Michaela Moestl, MD, Christoph Tinchon, MD, Elisabeth Koller, MD, Werner Linkesch, Univ. Prof, MD, Felix Keil, MD
Journal: Blood
Blood (2014) 124 (21): 3982.
https://doi.org/10.1182/blood.V124.21.3982.3982
Published: 2014